Verve Therapeutics, Inc.

VERV · NASDAQ
Analyze with AI
$11.13+$0.03 (+0.27%)
At close:Jul 25, 2025, 8:00 PM UTC
$11.20+$0.07 (+0.63%)
After hours:Jul 24, 2025, 11:37 PM UTC
P/E TTM-5.46
P/B TTM2.09
P/S TTM16.67
Dividend Yield0%
EPS-$2.11
Beta2.237
Valuation
PEG Ratio-0.53
FCF Yield-14.79%
EV / EBITDA-4.79
More On Valuation »
Quality
ROIC-36.46%
Gross Margin100.00%
Cash Conv. Ratio0.79
More On Quality »
Growth
Revenue 3Y CAGR155.39%
FCF Growth-1.63%
More On Growth »
Safety
Net Debt / EBITDA0.14
Interest Coverage0.00
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle8.57
More On Efficiency »

Verve Therapeutics, Inc. (VERV) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Verve Therapeutics, Inc. (VERV) stock price today?

As of Jul 25, 2025, 8:00 PM UTC, Verve Therapeutics, Inc. (VERV) stock is trading at $11.13. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date VERV stock quotes for informed trading decisions.

What is Verve Therapeutics, Inc.'s market capitalization?

Verve Therapeutics, Inc. (VERV) has a market capitalization of approximately $994.0M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Verve Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the VERV stock price changes.

What is the 52-week range for Verve Therapeutics, Inc. stock?

Verve Therapeutics, Inc. (VERV) stock has traded in a 52-week range of $2.87 — $11.41. The 52-week range shows the highest and lowest prices at which VERV traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Verve Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Verve Therapeutics, Inc. stock have?

Verve Therapeutics, Inc. (VERV) stock recently traded approximately 10.3M shares. Trading volume indicates market liquidity and investor interest in VERV. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Verve Therapeutics, Inc. stock.

Does Verve Therapeutics, Inc. pay dividends to shareholders?

Yes, Verve Therapeutics, Inc. (VERV) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Verve Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Verve Therapeutics, Inc.'s intraday price range?

Today, Verve Therapeutics, Inc. (VERV) stock has traded in a range of $11.13 — $11.13. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring VERV's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Verve Therapeutics, Inc. stock data?

AlphaPilot sources real-time VERV stock quotes, fundamental financial data, and historical price charts for Verve Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Verve Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of VERV stock performance.